Option Care Health Financials - Benzinga

Option Care Health Inc

OPCHNASDAQ

Trade with Public

Trade with Public

$23.07

-0.27-1.16%

Dern. MÀJ: Sep 24, 12:32 PM

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Comparer Options Rapport sur les stocks

Option Care Health Financials

Option Care Health (OPCH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Option Care Health Q2 Adj. EPS $0.45 Beats $0.43 Estimate, Sales $1.442B Beat $1.419B Estimate

Option Care Health (NASDAQ:OPCH) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.43 by 4.65 percent. This is a 9.76 percent increase over earnings of $0.41 per share from

Benzinga Newsdesk

PRO
Option Care Health Raises FY2026 Adj EPS Guidance from $1.82-$1.92 to $1.85-$1.92 vs $1.84 Est; Affirms FY2026 Sales Guidance of $5.675B-$5.775B vs $5.711B Est

Option Care Health (NASDAQ:OPCH) raises FY2026 Adj EPS guidance from $1.82-$1.92 to $1.85-$1.92 vs $1.84 analyst estimate. Affirms FY2026 sales outlook from $5.675 billion-$5.775 billion to $5.675 billion-$5.775 billion

Benzinga Newsdesk

Dow Jumps 300 POints; Amazon Posts Upbeat Earnings

US stocks mixed as Dow gains 300 points, Amazon reports upbeat Q1 results. Industrials up 1.5%, tech down 0.8%. Oil down 1%, gold up 1.7%.

Avi Kapoor

PRO
Option Care Health Affirms FY2026 Adj EPS Guidance of $1.82-$1.92 vs $1.86 Est; Lowers FY2026 Sales Guidance from $5.800B-$6.000B to $5.675B-$5.775B vs $5.938B Est

Option Care Health (NASDAQ:OPCH) affirms FY2026 Adj EPS guidance from $1.82-$1.92 to $1.82-$1.92 vs $1.86 analyst estimate. Lowers FY2026 sales outlook from $5.800 billion-$6.000 billion to $5.675 billion-$5.775 billion

Benzinga Newsdesk

Earnings Scheduled For April 30, 2026

Benzinga Insights

PRO
Option Care Health Q1 Adj. EPS $0.40 Beats $0.37 Estimate, Sales $1.351B Miss $1.397B Estimate

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved